CARBIDOPA LEVODOPA

CARBIDOPA LEVODOPA was reported 3539 times

CARBIDOPA LEVODOPA is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SPEECH-LANGUAGE THERAPY 3 0.1765
1 ADJACENT SEGMENT DEGENERATION 2 0.0800
2 OCCUPATIONAL THERAPY 3 0.0667
3 RESPITE CARE 2 0.0513
4 PARKINSONISM HYPERPYREXIA SYNDROME 9 0.0503
5 DYSKINESIA HYPERPYREXIA SYNDROME 2 0.0426
6 AMIMIA 3 0.0273
7 DEEP BRAIN STIMULATION 15 0.0248
8 DOPAMINE DYSREGULATION SYNDROME 11 0.0247
9 OEDEMA DUE TO CARDIAC DISEASE 3 0.0214
10 PHYSIOTHERAPY 11 0.0213
11 DEFICIENCY ANAEMIA 2 0.0211
12 ACUTE POLYNEUROPATHY 6 0.0210
13 DELUSION OF REPLACEMENT 2 0.0200
14 MEDICAL DEVICE SITE IRRITATION 2 0.0196
15 STOMA SITE OEDEMA 4 0.0183
16 STOMA SITE EXTRAVASATION 7 0.0181
17 SUPINE HYPERTENSION 3 0.0159
18 CATHETER SITE NODULE 3 0.0157
19 MEDICAL DEVICE BATTERY REPLACEMENT 2 0.0148
20 BLOOD CHOLINESTERASE DECREASED 4 0.0146
21 STOMA SITE INFECTION 18 0.0138
22 PATIENT ELOPEMENT 5 0.0137
23 STOMA SITE ODOUR 3 0.0134
24 SMALL INTESTINAL ULCER HAEMORRHAGE 2 0.0132
25 STOMA SITE REACTION 9 0.0131
26 FREEZING PHENOMENON 48 0.0130
27 STOMA COMPLICATION 13 0.0128
28 RAPID EYE MOVEMENT SLEEP BEHAVIOUR DISORDER 5 0.0124
29 VITAMIN B6 DEFICIENCY 3 0.0122
30 HAND-EYE COORDINATION IMPAIRED 2 0.0118
31 STOMA SITE ERYTHEMA 21 0.0112
32 HALLUCINATIONS, MIXED 46 0.0109
33 STOMA SITE DISCHARGE 29 0.0106
34 DEVICE COLOUR ISSUE 4 0.0099
35 STOMA SITE HAEMORRHAGE 15 0.0097
36 BLADDER CATHETERISATION 9 0.0093
37 DEMENTIA WITH LEWY BODIES 10 0.0090
38 SALIVA DISCOLOURATION 3 0.0090
39 MULTIPLE SYSTEM ATROPHY 3 0.0085
40 ENVIRONMENTAL EXPOSURE 2 0.0084
41 CHRONIC LEFT VENTRICULAR FAILURE 3 0.0083
42 OESOPHAGEAL MOTILITY DISORDER 3 0.0083
43 DELUSION 123 0.0079
44 STOMA SITE PAIN 11 0.0075
45 STOMA SITE IRRITATION 4 0.0074
46 INFUSION SITE NODULE 7 0.0073
47 REHABILITATION THERAPY 27 0.0070
48 LIVING IN RESIDENTIAL INSTITUTION 13 0.0069
49 NONSPECIFIC REACTION 38 0.0069
50 ON AND OFF PHENOMENON 38 0.0068
51 SLOW SPEECH 16 0.0066
52 HALLUCINATION, VISUAL 137 0.0065
53 BRADYKINESIA 38 0.0064
54 HALLUCINATION 479 0.0063
55 DEVICE PROGRAMMING ERROR 2 0.0063
56 ANKLE DEFORMITY 2 0.0062
57 RESTING TREMOR 4 0.0062
58 DEVICE ALARM ISSUE 11 0.0061
59 CATHETER SITE BRUISE 2 0.0060
60 YAWNING 16 0.0060
61 REDUCED FACIAL EXPRESSION 6 0.0059
62 DIAPHRAGMALGIA 2 0.0058
63 INFUSION SITE CELLULITIS 3 0.0057
64 MEDICAL DEVICE CHANGE 3 0.0056
65 DROPPED HEAD SYNDROME 2 0.0051
66 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 5 0.0050
67 DEVICE KINK 18 0.0049
68 HYPERSEXUALITY 9 0.0049
69 NEURODEGENERATIVE DISORDER 3 0.0049
70 STOMA SITE HYPERGRANULATION 3 0.0048
71 BELLIGERENCE 2 0.0047
72 DEVICE BATTERY ISSUE 3 0.0046
73 HALLUCINATION, TACTILE 3 0.0045
74 DELUSION OF GRANDEUR 2 0.0045
75 HEAT ILLNESS 3 0.0044
76 SKIN DEPIGMENTATION 6 0.0044
77 THERAPEUTIC PRODUCT EFFECT VARIABLE 17 0.0044
78 LIPIDS ABNORMAL 3 0.0041
79 SLEEP TALKING 7 0.0041
80 LABELLED DRUG-FOOD INTERACTION MEDICATION ERROR 2 0.0040
81 IMPULSE-CONTROL DISORDER 8 0.0039
82 HOSPICE CARE 38 0.0038
83 LEFT ATRIAL ENLARGEMENT 2 0.0037
84 FEAR OF FALLING 3 0.0037
85 FOOD REFUSAL 3 0.0034
86 INFUSION SITE DISCOLOURATION 3 0.0034
87 DEVICE CONNECTION ISSUE 7 0.0033
88 SITTING DISABILITY 2 0.0032
89 PARKINSONIAN GAIT 2 0.0032
90 STEREOTYPY 3 0.0032
91 ANTICHOLINERGIC SYNDROME 5 0.0031
92 MUCOSAL DISCOLOURATION 2 0.0031
93 NEUROPATHIC ARTHROPATHY 2 0.0031
94 SLOW RESPONSE TO STIMULI 4 0.0031
95 DYSKINESIA 125 0.0031
96 VOLVULUS 7 0.0030
97 DERMATITIS PSORIASIFORM 6 0.0029
98 DEVICE OCCLUSION 41 0.0029
99 RADIOISOTOPE SCAN ABNORMAL 2 0.0028
100 PRODUCT RESIDUE PRESENT 15 0.0028
101 BITE 2 0.0028
102 POSTURE ABNORMAL 9 0.0028
103 DELUSIONAL DISORDER, UNSPECIFIED TYPE 2 0.0027
104 CATHETER SITE RELATED REACTION 2 0.0027
105 THERAPEUTIC PRODUCT EFFECT DELAYED 12 0.0026
106 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 6 0.0026
107 PROSTATOMEGALY 10 0.0025
108 DEMENTIA 71 0.0025
109 PARANOIA 43 0.0025
110 CARDIAC DEATH 3 0.0025
111 CARTILAGE ATROPHY 2 0.0025
112 DROOLING 17 0.0025
113 INFUSION SITE WARMTH 3 0.0024
114 ILLUSION 4 0.0024
115 FINE MOTOR SKILL DYSFUNCTION 7 0.0024
116 DYSCHROMATOPSIA 2 0.0024
117 INFUSION SITE BRUISING 5 0.0023
118 BLOOD SODIUM INCREASED 6 0.0022
119 LIGAMENT DISORDER 2 0.0022
120 NASAL DISCHARGE DISCOLOURATION 3 0.0022
121 DISCHARGE 3 0.0022
122 COMMUNICATION DISORDER 8 0.0021
123 PRECANCEROUS SKIN LESION 3 0.0020
124 MUSCLE RIGIDITY 24 0.0020
125 AKINESIA 4 0.0019
126 PRODUCT BLISTER PACKAGING ISSUE 2 0.0019
127 LIVEDO RETICULARIS 4 0.0019
128 MEDICAL DEVICE IMPLANTATION 3 0.0019
129 EYE CONTUSION 4 0.0019
130 HYPERSOMNIA 54 0.0019
131 HYDROCELE 2 0.0019
132 DEVICE INEFFECTIVE 2 0.0019
133 PRODUCT DISPENSING ISSUE 8 0.0019
134 BINGE EATING 2 0.0019
135 MEDICAL PROCEDURE 3 0.0018
136 HIP FRACTURE 57 0.0018
137 GAZE PALSY 3 0.0018
138 MEDICAL DEVICE REMOVAL 3 0.0017
139 DEVICE POWER SOURCE ISSUE 5 0.0017
140 HYPORESPONSIVE TO STIMULI 2 0.0017
141 INCISION SITE PAIN 2 0.0017
142 THORACIC VERTEBRAL FRACTURE 5 0.0017
143 DYSGRAPHIA 11 0.0017
144 METABOLIC ENCEPHALOPATHY 5 0.0017
145 PROSTATIC OPERATION 2 0.0017
146 INITIAL INSOMNIA 17 0.0017
147 SKIN LACERATION 18 0.0017
148 MEDICAL DEVICE DISCOMFORT 5 0.0016
149 FRACTURED SACRUM 2 0.0016
150 TOXIC ENCEPHALOPATHY 8 0.0016
151 ABNORMAL BEHAVIOUR 62 0.0016
152 BALANCE DISORDER 133 0.0015
153 PARKINSONISM 15 0.0015
154 COLOSTOMY 3 0.0015
155 LIP INJURY 2 0.0015
156 DECREASED INTEREST 9 0.0015
157 INTENTIONAL UNDERDOSE 11 0.0015
158 COMPULSIVE SHOPPING 3 0.0015
159 INFUSION SITE RASH 2 0.0015
160 CERVICAL VERTEBRAL FRACTURE 5 0.0014
161 RHONCHI 2 0.0014
162 BILIARY TRACT DISORDER 2 0.0014
163 PNEUMONIA ASPIRATION 36 0.0014
164 SLEEP TERROR 6 0.0014
165 SLEEP DEFICIT 3 0.0014
166 INTENSIVE CARE 2 0.0014
167 FACIAL BONES FRACTURE 5 0.0014
168 LANGUAGE DISORDER 3 0.0014
169 HALLUCINATION, AUDITORY 22 0.0014
170 REFUSAL OF TREATMENT BY PATIENT 9 0.0014
171 ABNORMAL DREAMS 38 0.0014
172 HEART VALVE REPLACEMENT 2 0.0014
173 INFUSION SITE INDURATION 2 0.0013
174 PARESIS 3 0.0013
175 SPINAL COLUMN INJURY 3 0.0013
176 CONFUSIONAL STATE 217 0.0013
177 ADHESION 2 0.0013
178 DEVICE USE ISSUE 23 0.0013
179 FALL 436 0.0013
180 PALLIATIVE CARE 2 0.0013
181 BLOOD PRESSURE IMMEASURABLE 2 0.0013
182 DYSSTASIA 38 0.0013
183 INFUSION SITE INFECTION 3 0.0013
184 GASTROSTOMY 2 0.0013
185 DYSTONIA 25 0.0013
186 FEELING OF DESPAIR 6 0.0013
187 PELVIC FRACTURE 10 0.0013
188 ORAL SURGERY 3 0.0013
189 CHOKING 25 0.0013
190 URINARY TRACT OBSTRUCTION 3 0.0013
191 HEAD INJURY 40 0.0013
192 SPEECH DISORDER 66 0.0013
193 SKULL FRACTURE 2 0.0012
194 MIDDLE INSOMNIA 23 0.0012
195 SHOULDER FRACTURE 2 0.0012
196 BLOOD CALCIUM ABNORMAL 2 0.0012
197 GASTROINTESTINAL TUBE INSERTION 3 0.0012
198 TERMINAL STATE 8 0.0012
199 SPLEEN DISORDER 2 0.0012
200 SKIN WOUND 2 0.0012
201 IMMOBILE 5 0.0011
202 FOOD INTERACTION 2 0.0011
203 KYPHOSIS 2 0.0011
204 NIGHTMARE 39 0.0011
205 UNINTENTIONAL MEDICAL DEVICE REMOVAL 13 0.0011
206 ANAESTHETIC COMPLICATION 3 0.0011
207 ABDOMINAL RIGIDITY 3 0.0011
208 HYPOKINESIA 16 0.0011
209 SCREAMING 7 0.0011
210 CUTANEOUS VASCULITIS 4 0.0011
211 FAECALOMA 6 0.0011
212 ORTHOSTATIC HYPOTENSION 19 0.0011
213 PNEUMONIA KLEBSIELLA 2 0.0011
214 PSYCHIATRIC SYMPTOM 8 0.0011
215 CATHETER PLACEMENT 2 0.0011
216 ARTHRITIS INFECTIVE 5 0.0011
217 PERSONALITY CHANGE 10 0.0011
218 MICTURITION URGENCY 12 0.0010
219 GAIT INABILITY 35 0.0010
220 CUTANEOUS LUPUS ERYTHEMATOSUS 2 0.0010
221 TREMOR 170 0.0010
222 LIBIDO INCREASED 2 0.0010
223 FAILURE TO THRIVE 5 0.0010
224 DEVICE MATERIAL ISSUE 2 0.0010
225 INFUSION SITE PRURITUS 3 0.0009
226 TESTICULAR PAIN 3 0.0009
227 DRUG EFFECT LESS THAN EXPECTED 14 0.0009
228 HYPERKINESIA 2 0.0009
229 BILE DUCT STONE 3 0.0009
230 DEVICE DISLOCATION 41 0.0009
231 RENAL NEOPLASM 2 0.0009
232 C-REACTIVE PROTEIN ABNORMAL 6 0.0009
233 MOBILITY DECREASED 67 0.0009
234 URINARY TRACT INFECTION 159 0.0009
235 RESTLESSNESS 34 0.0009
236 INCOHERENT 6 0.0009
237 BEHAVIOUR DISORDER 5 0.0009
238 DYSPHAGIA 87 0.0009
239 GAIT DISTURBANCE 175 0.0009
240 DEVICE PHYSICAL PROPERTY ISSUE 7 0.0009
241 ASPIRATION 10 0.0009
242 COLONOSCOPY 2 0.0009
243 WHEELCHAIR USER 4 0.0009
244 ANXIETY DISORDER 3 0.0009
245 MOTOR DYSFUNCTION 9 0.0009
246 RESTLESS LEGS SYNDROME 16 0.0009
247 DISLOCATION OF VERTEBRA 2 0.0009
248 BRAIN OPERATION 2 0.0009
249 NERVE COMPRESSION 8 0.0009
250 FLAT AFFECT 2 0.0009
251 HYPOPHAGIA 22 0.0009
252 AGGRESSION 43 0.0009
253 UNRESPONSIVE TO STIMULI 22 0.0009
254 LOGORRHOEA 3 0.0009
255 SPUTUM DISCOLOURED 8 0.0008
256 MOVEMENT DISORDER 27 0.0008
257 DISTURBANCE IN ATTENTION 45 0.0008
258 DEVICE ISSUE 74 0.0008
259 PRODUCT PACKAGING CONFUSION 2 0.0008
260 NOCTURIA 10 0.0008
261 THERAPEUTIC RESPONSE SHORTENED 27 0.0008
262 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 39 0.0008
263 SPINAL OPERATION 10 0.0008
264 DEVICE INFUSION ISSUE 2 0.0008
265 THINKING ABNORMAL 15 0.0008
266 INFREQUENT BOWEL MOVEMENTS 2 0.0008
267 PRE-EXISTING CONDITION IMPROVED 5 0.0008
268 CATHETER SITE HAEMORRHAGE 2 0.0008
269 FLUID INTAKE REDUCED 4 0.0008
270 BLOOD PRESSURE FLUCTUATION 19 0.0008
271 BOWEL MOVEMENT IRREGULARITY 6 0.0008
272 ANAL INCONTINENCE 7 0.0008
273 RIB FRACTURE 16 0.0008
274 ACTINIC KERATOSIS 2 0.0008
275 PRODUCT PACKAGING DIFFICULT TO OPEN 2 0.0008
276 WALKING AID USER 5 0.0008
277 JOINT INJURY 16 0.0007
278 AGITATION 55 0.0007
279 GASTROINTESTINAL MOTILITY DISORDER 4 0.0007
280 PSYCHOTIC DISORDER 22 0.0007
281 GALLBLADDER OPERATION 3 0.0007
282 GAMBLING DISORDER 2 0.0007
283 DECUBITUS ULCER 6 0.0007
284 GASTRIC PERFORATION 2 0.0007
285 FOOT DEFORMITY 8 0.0007
286 CHOLECYSTITIS INFECTIVE 2 0.0007
287 DELIRIUM 25 0.0007
288 PRODUCT DOSE OMISSION ISSUE 211 0.0007
289 SOMNOLENCE 144 0.0007
290 ENDOTRACHEAL INTUBATION 2 0.0007
291 BLOOD PRESSURE DECREASED 47 0.0007
292 PRODUCT DOSE OMISSION IN ERROR 20 0.0007
293 AORTIC VALVE INCOMPETENCE 3 0.0007
294 JOINT LOCK 2 0.0007
295 BLOOD PRESSURE ABNORMAL 14 0.0007
296 PRESCRIBED UNDERDOSE 14 0.0007
297 PRODUCT USE COMPLAINT 11 0.0007
298 EXERCISE TOLERANCE DECREASED 4 0.0007
299 MOUTH SWELLING 4 0.0007
300 HYPERTONIC BLADDER 2 0.0007
301 THERAPEUTIC RESPONSE UNEXPECTED 31 0.0007
302 BONE CANCER 3 0.0007
303 BEDRIDDEN 9 0.0007
304 MEMORY IMPAIRMENT 94 0.0007
305 DYSPHEMIA 3 0.0007
306 GRIP STRENGTH DECREASED 6 0.0007
307 SEROTONIN SYNDROME 13 0.0007
308 CATARACT OPERATION 4 0.0007
309 INFUSION SITE REACTION 2 0.0007
310 MANIA 11 0.0007
311 NORMOCHROMIC NORMOCYTIC ANAEMIA 2 0.0007
312 DEVICE BREAKAGE 27 0.0007
313 PSYCHOMOTOR HYPERACTIVITY 11 0.0007
314 APHASIA 20 0.0007
315 JOINT DISLOCATION 7 0.0007
316 CRANIOCEREBRAL INJURY 2 0.0007
317 URINE ABNORMALITY 3 0.0007
318 EMERGENCY CARE 2 0.0007
319 INGUINAL HERNIA 4 0.0007
320 LUMBAR VERTEBRAL FRACTURE 3 0.0007
321 BODY HEIGHT DECREASED 7 0.0007
322 ISCHAEMIC CARDIOMYOPATHY 2 0.0007
323 UROSEPSIS 6 0.0006
324 BACK INJURY 7 0.0006
325 COGNITIVE DISORDER 30 0.0006
326 CONSTIPATION 140 0.0006
327 INFUSION SITE SWELLING 4 0.0006
328 INTENTIONAL DOSE OMISSION 18 0.0006
329 ATRIAL FLUTTER 5 0.0006
330 LIMB INJURY 17 0.0006
331 TRANSIENT ISCHAEMIC ATTACK 21 0.0006
332 DIZZINESS POSTURAL 6 0.0006
333 PRODUCT DOSE OMISSION 40 0.0006
334 SOMNAMBULISM 4 0.0006
335 INFUSION SITE HAEMORRHAGE 2 0.0006
336 LISTLESS 2 0.0006
337 FOOT OPERATION 3 0.0006
338 DISORIENTATION 24 0.0006
339 ANEURYSM 3 0.0006
340 SALIVARY HYPERSECRETION 6 0.0006
341 PROSTATE CANCER METASTATIC 2 0.0006
342 INFUSION SITE ERYTHEMA 5 0.0006
343 ADVERSE DRUG REACTION 53 0.0006
344 SLUGGISHNESS 6 0.0006
345 EYE MOVEMENT DISORDER 4 0.0006
346 WRIST FRACTURE 7 0.0006
347 PERIPHERAL COLDNESS 8 0.0006
348 SLEEP DISORDER 41 0.0006
349 GRANULOMA 2 0.0006
350 PERIPHERAL SWELLING 89 0.0006
351 HYPERREFLEXIA 2 0.0006
352 CATATONIA 3 0.0006
353 CYSTITIS 18 0.0006
354 HAND FRACTURE 4 0.0006
355 SKIN WEEPING 2 0.0006
356 POOR QUALITY SLEEP 12 0.0006
357 LETHARGY 32 0.0006
358 CHOKING SENSATION 3 0.0005
359 CARDIAC DYSFUNCTION 2 0.0005
360 MALNUTRITION 6 0.0005
361 IMPULSIVE BEHAVIOUR 2 0.0005
362 CATHETER SITE INFECTION 2 0.0005
363 FACE INJURY 2 0.0005
364 CONDITION AGGRAVATED 160 0.0005
365 CLAVICLE FRACTURE 2 0.0005
366 DEVICE RELATED INFECTION 8 0.0005
367 OESOPHAGEAL DISORDER 2 0.0005
368 PRESCRIBED OVERDOSE 10 0.0005
369 CONCUSSION 4 0.0005
370 PANIC DISORDER 2 0.0005
371 STRESS CARDIOMYOPATHY 3 0.0005
372 RHINOVIRUS INFECTION 2 0.0005
373 MUSCULOSKELETAL STIFFNESS 45 0.0005
374 PERIPHERAL SENSORY NEUROPATHY 3 0.0005
375 BODY TEMPERATURE DECREASED 5 0.0005
376 IDIOPATHIC PULMONARY FIBROSIS 2 0.0005
377 HYPERPHAGIA 2 0.0005
378 OBSESSIVE-COMPULSIVE DISORDER 4 0.0005
379 SQUAMOUS CELL CARCINOMA OF SKIN 3 0.0005
380 BLINDNESS UNILATERAL 7 0.0005
381 ENURESIS 2 0.0005
382 FEEDING DISORDER 10 0.0005
383 TENSION 3 0.0005
384 LOSS OF CONSCIOUSNESS 63 0.0005
385 THERAPEUTIC PRODUCT EFFECT DECREASED 22 0.0005
386 ABNORMAL FAECES 4 0.0005
387 ARTHRITIS BACTERIAL 2 0.0005
388 SELF-MEDICATION 2 0.0005
389 INSOMNIA 129 0.0005
390 EYE DISCHARGE 5 0.0005
391 NEPHROLITHIASIS 22 0.0005
392 SECRETION DISCHARGE 6 0.0005
393 DYSARTHRIA 18 0.0005
394 KNEE ARTHROPLASTY 10 0.0005
395 INCONTINENCE 5 0.0005
396 VITAMIN D DECREASED 4 0.0005
397 SHOULDER OPERATION 2 0.0005
398 ROTATOR CUFF SYNDROME 6 0.0005
399 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 8 0.0005
400 INFUSION SITE PAIN 6 0.0005
401 CARDIAC FLUTTER 3 0.0005
402 MONOPLEGIA 2 0.0005
403 RESPIRATORY SYNCYTIAL VIRUS INFECTION 4 0.0005
404 BRADYPHRENIA 3 0.0005
405 POLYP 3 0.0005
406 WOUND INFECTION 5 0.0005
407 MELANOCYTIC NAEVUS 2 0.0005
408 ARTERIOSCLEROSIS CORONARY ARTERY 3 0.0005
409 LIGAMENT RUPTURE 2 0.0005
410 APPETITE DISORDER 3 0.0005
411 ABDOMINAL ABSCESS 2 0.0005
412 SPINAL FRACTURE 9 0.0004
413 ILEUS PARALYTIC 2 0.0004
414 POST-TRAUMATIC STRESS DISORDER 3 0.0004
415 SKIN INFECTION 5 0.0004
416 POSTOPERATIVE WOUND INFECTION 3 0.0004
417 ASTHENIA 167 0.0004
418 GENERAL PHYSICAL HEALTH DETERIORATION 51 0.0004
419 ABDOMINAL HERNIA 2 0.0004
420 IMMUNE THROMBOCYTOPENIA 2 0.0004
421 PROSTATIC SPECIFIC ANTIGEN INCREASED 6 0.0004
422 LOCALISED OEDEMA 2 0.0004
423 MUSCLE TIGHTNESS 7 0.0004
424 PRODUCT DISTRIBUTION ISSUE 4 0.0004
425 DEPRESSION 98 0.0004
426 AMNESIA 28 0.0004
427 DEATH 370 0.0004
428 ROSACEA 2 0.0004
429 APPENDICITIS 4 0.0004
430 ILL-DEFINED DISORDER 26 0.0004
431 APPLICATION SITE REACTION 3 0.0004
432 DIPLOPIA 11 0.0004
433 SKIN ABRASION 2 0.0004
434 MUSCULOSKELETAL DISORDER 8 0.0004
435 MACULAR DEGENERATION 5 0.0004
436 LOWER LIMB FRACTURE 8 0.0004
437 ANOSMIA 6 0.0004
438 SINUS BRADYCARDIA 4 0.0004
439 HERNIA 8 0.0004
440 HEMIPARESIS 7 0.0004
441 COMPLICATION ASSOCIATED WITH DEVICE 6 0.0004
442 FAECES SOFT 3 0.0004
443 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 29 0.0004
444 ENCEPHALOPATHY 10 0.0004
445 STAPHYLOCOCCAL SEPSIS 2 0.0004
446 DIZZINESS 202 0.0004
447 ARTHROPOD BITE 3 0.0004
448 EMBEDDED DEVICE 4 0.0004
449 VISUAL IMPAIRMENT 50 0.0004
450 HYPERNATRAEMIA 2 0.0004
451 BLOOD POTASSIUM DECREASED 12 0.0004
452 MUSCULAR WEAKNESS 45 0.0004
453 DYSPHORIA 2 0.0004
454 HYPOACUSIS 17 0.0004
455 SURGERY 23 0.0004
456 CEREBRAL HAEMORRHAGE 14 0.0004
457 FEMORAL NECK FRACTURE 2 0.0004
458 ENDOCARDITIS 2 0.0004
459 PRODUCT COLOUR ISSUE 2 0.0004
460 INCREASED UPPER AIRWAY SECRETION 2 0.0004
461 CACHEXIA 2 0.0004
462 LIMB DISCOMFORT 12 0.0004
463 FEMUR FRACTURE 12 0.0004
464 ANXIETY 110 0.0004
465 ANGER 13 0.0004
466 PANIC ATTACK 14 0.0004
467 FEELING ABNORMAL 92 0.0004
468 ELECTROCARDIOGRAM ABNORMAL 3 0.0004
469 AFFECTIVE DISORDER 3 0.0004
470 BLOOD LACTIC ACID INCREASED 2 0.0004
471 THROAT IRRITATION 17 0.0004
472 SARS-COV-2 TEST POSITIVE 5 0.0004
473 DYSPHONIA 22 0.0004
474 EATING DISORDER 8 0.0004
475 RETCHING 8 0.0004
476 DEHYDRATION 50 0.0004
477 MIOSIS 3 0.0004
478 FOOD POISONING 2 0.0004
479 FEAR 10 0.0004
480 MENTAL IMPAIRMENT 9 0.0004
481 URINARY INCONTINENCE 11 0.0004
482 UNEVALUABLE EVENT 28 0.0004
483 FRACTURE 7 0.0004
484 BLOOD POTASSIUM INCREASED 6 0.0004
485 HIP SURGERY 2 0.0004
486 PRODUCT TASTE ABNORMAL 5 0.0004
487 POST PROCEDURAL INFECTION 3 0.0004
488 HYPOTENSION 74 0.0004
489 SEPSIS 41 0.0004
490 PALLOR 10 0.0004
491 MOOD ALTERED 10 0.0004
492 POLYURIA 3 0.0004
493 CORONARY ARTERY OCCLUSION 5 0.0004
494 UPPER-AIRWAY COUGH SYNDROME 3 0.0004
495 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 17 0.0004
496 INTESTINAL ISCHAEMIA 2 0.0004
497 DEAFNESS UNILATERAL 2 0.0004
498 SPINAL COMPRESSION FRACTURE 3 0.0004
499 BLOOD PRESSURE INCREASED 55 0.0004
500 ATRIAL FIBRILLATION 35 0.0004
501 DEPRESSED MOOD 19 0.0004
502 HEART RATE ABNORMAL 2 0.0004
503 KIDNEY INFECTION 7 0.0004
504 WEIGHT DECREASED 99 0.0004
505 COVID-19 62 0.0004
506 SEASONAL ALLERGY 5 0.0004
507 DERMATITIS CONTACT 4 0.0004
508 CHOLECYSTECTOMY 4 0.0003
509 INTERNAL HAEMORRHAGE 4 0.0003
510 CARDIAC VALVE DISEASE 2 0.0003
511 SUBDURAL HAEMATOMA 5 0.0003
512 SKIN ATROPHY 2 0.0003
513 DEVICE DIFFICULT TO USE 23 0.0003
514 SKIN WARM 2 0.0003
515 CONTUSION 33 0.0003
516 HEART RATE DECREASED 12 0.0003
517 SEXUAL DYSFUNCTION 4 0.0003
518 COUGH 95 0.0003
519 EAR INFECTION 9 0.0003
520 NEUROLEPTIC MALIGNANT SYNDROME 4 0.0003
521 CARDIOTOXICITY 3 0.0003
522 CARDIAC PACEMAKER INSERTION 2 0.0003
523 URINARY RETENTION 11 0.0003
524 PRESYNCOPE 8 0.0003
525 DEVICE DELIVERY SYSTEM ISSUE 9 0.0003
526 BRAIN NEOPLASM 3 0.0003
527 HIP ARTHROPLASTY 5 0.0003
528 GLOMERULAR FILTRATION RATE DECREASED 4 0.0003
529 MENISCUS INJURY 2 0.0003
530 FEELING COLD 9 0.0003
531 INCORRECT PRODUCT ADMINISTRATION DURATION 7 0.0003
532 ALTERED STATE OF CONSCIOUSNESS 7 0.0003
533 SCOLIOSIS 2 0.0003
534 DRY MOUTH 26 0.0003
535 CATARACT 19 0.0003
536 BRAIN FOG 5 0.0003
537 LACERATION 3 0.0003
538 BLEPHAROSPASM 2 0.0003
539 PNEUMOTHORAX 5 0.0003
540 UNDERDOSE 23 0.0003
541 INCREASED APPETITE 6 0.0003
542 POLLAKIURIA 13 0.0003
543 SENSORY DISTURBANCE 5 0.0003
544 ERECTILE DYSFUNCTION 8 0.0003
545 APPLICATION SITE PRURITUS 7 0.0003
546 VITAMIN D DEFICIENCY 3 0.0003
547 BACK DISORDER 5 0.0003
548 PHARYNGEAL SWELLING 3 0.0003
549 SEDATION 8 0.0003
550 KNEE OPERATION 3 0.0003
551 PRODUCT PREPARATION ISSUE 2 0.0003
552 LIGAMENT SPRAIN 3 0.0003
553 UPPER LIMB FRACTURE 6 0.0003
554 SKIN MASS 2 0.0003
555 MENINGITIS 2 0.0003
556 LEFT VENTRICULAR DYSFUNCTION 2 0.0003
557 COLITIS ISCHAEMIC 2 0.0003
558 DYSPEPSIA 29 0.0003
559 ABNORMAL LOSS OF WEIGHT 2 0.0003
560 APPLICATION SITE RASH 4 0.0003
561 PNEUMONIA 94 0.0003
562 RESPIRATION ABNORMAL 2 0.0003
563 OEDEMA PERIPHERAL 35 0.0003
564 NERVOUSNESS 15 0.0003
565 WEIGHT FLUCTUATION 3 0.0003
566 WOUND 8 0.0003
567 DEFAECATION URGENCY 2 0.0003
568 COLD SWEAT 5 0.0003
569 SUDDEN DEATH 3 0.0003
570 IRRITABILITY 17 0.0003
571 GALLBLADDER DISORDER 5 0.0003
572 PRODUCT ADHESION ISSUE 10 0.0003
573 DECREASED APPETITE 65 0.0003
574 SKIN CANCER 6 0.0003
575 DECREASED ACTIVITY 3 0.0003
576 PANIC REACTION 2 0.0003
577 DEVICE LEAKAGE 12 0.0003
578 BIPOLAR DISORDER 3 0.0003
579 PRODUCT PRESCRIBING ISSUE 6 0.0003
580 RASH PUSTULAR 2 0.0003
581 INTERVERTEBRAL DISC PROTRUSION 6 0.0003
582 THERAPY CESSATION 14 0.0003
583 DYSURIA 10 0.0003
584 SENSITIVE SKIN 2 0.0003
585 BLOOD PRESSURE DIASTOLIC DECREASED 2 0.0003
586 CEREBRAL DISORDER 2 0.0003
587 SKIN HAEMORRHAGE 4 0.0003
588 SYNCOPE 27 0.0003
589 DRUG INEFFECTIVE 354 0.0003
590 PULMONARY MASS 4 0.0003
591 THERAPY NON-RESPONDER 12 0.0003
592 GENERAL SYMPTOM 2 0.0003
593 ACIDOSIS 2 0.0003
594 PROCEDURAL COMPLICATION 2 0.0003
595 THYROID DISORDER 4 0.0003
596 OSTEOARTHRITIS 11 0.0003
597 THROAT TIGHTNESS 7 0.0003
598 POST PROCEDURAL HAEMORRHAGE 3 0.0003
599 FATIGUE 199 0.0003
600 ARTERIAL OCCLUSIVE DISEASE 2 0.0003
601 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 18 0.0003
602 BLOOD IRON DECREASED 3 0.0003
603 THERAPY INTERRUPTED 18 0.0003
604 ACCIDENT 3 0.0003
605 ABDOMINAL DISCOMFORT 42 0.0003
606 LOCALISED INFECTION 6 0.0002
607 PRODUCT PHYSICAL ISSUE 5 0.0002
608 MUSCLE DISORDER 2 0.0002
609 BODY TEMPERATURE INCREASED 5 0.0002
610 CARDIOMEGALY 3 0.0002
611 ILLNESS 25 0.0002
612 SEIZURE 28 0.0002
613 APPLICATION SITE IRRITATION 3 0.0002
614 TOOTH EXTRACTION 3 0.0002
615 DRUG INTERACTION 38 0.0002
616 BLOOD UREA INCREASED 4 0.0002
617 INTESTINAL OBSTRUCTION 9 0.0002
618 THROMBOSIS 19 0.0002
619 RESPIRATORY DISORDER 7 0.0002
620 INFLUENZA 26 0.0002
621 HYPERHIDROSIS 30 0.0002
622 MUSCULOSKELETAL DISCOMFORT 4 0.0002
623 BLOOD MAGNESIUM DECREASED 2 0.0002
624 OXYGEN SATURATION DECREASED 13 0.0002
625 MUSCLE STRAIN 2 0.0002
626 CORONARY ARTERY DISEASE 7 0.0002
627 FAECES DISCOLOURED 5 0.0002
628 RESPIRATORY TRACT INFECTION 6 0.0002
629 INCORRECT DOSE ADMINISTERED BY DEVICE 6 0.0002
630 GROIN PAIN 2 0.0002
631 SPINAL OSTEOARTHRITIS 2 0.0002
632 ADVERSE REACTION 3 0.0002
633 CEREBROVASCULAR ACCIDENT 38 0.0002
634 SWOLLEN TONGUE 7 0.0002
635 MALIGNANT MELANOMA 3 0.0002
636 GASTROINTESTINAL INFECTION 2 0.0002
637 OROPHARYNGEAL DISCOMFORT 2 0.0002
638 HOSPITALISATION 34 0.0002
639 HEART RATE IRREGULAR 5 0.0002
640 OSTEOMYELITIS 4 0.0002
641 LIP DRY 2 0.0002
642 CRYING 8 0.0002
643 IMPAIRED GASTRIC EMPTYING 3 0.0002
644 DISEASE PROGRESSION 26 0.0002
645 PRODUCT AVAILABILITY ISSUE 5 0.0002
646 SKIN DISCOLOURATION 10 0.0002
647 RETINAL DETACHMENT 2 0.0002
648 NAUSEA 172 0.0002
649 MUSCLE TWITCHING 5 0.0002
650 UPPER RESPIRATORY TRACT INFECTION 10 0.0002
651 ARTHRITIS 17 0.0002
652 MENTAL STATUS CHANGES 6 0.0002
653 ORAL DISCOMFORT 3 0.0002
654 RHABDOMYOLYSIS 9 0.0002
655 COORDINATION ABNORMAL 3 0.0002
656 WITHDRAWAL SYNDROME 9 0.0002
657 BLOOD TEST ABNORMAL 3 0.0002
658 SQUAMOUS CELL CARCINOMA 2 0.0002
659 BLOOD SODIUM DECREASED 4 0.0002
660 GASTROINTESTINAL DISORDER 19 0.0002
661 PAIN IN JAW 6 0.0002
662 CARDIAC FAILURE CONGESTIVE 17 0.0002
663 DIALYSIS 3 0.0002
664 HAEMATOTOXICITY 2 0.0002
665 PRODUCT PACKAGING ISSUE 2 0.0002
666 COMA 10 0.0002
667 FEELING JITTERY 4 0.0002
668 POST PROCEDURAL COMPLICATION 4 0.0002
669 ACUTE RESPIRATORY FAILURE 4 0.0002
670 GLAUCOMA 4 0.0002
671 JOINT SWELLING 25 0.0002
672 MENTAL DISORDER 9 0.0002
673 BLOOD PRESSURE SYSTOLIC INCREASED 4 0.0002
674 BLADDER DISORDER 2 0.0002
675 RHINORRHOEA 13 0.0002
676 PULMONARY OEDEMA 9 0.0002
677 MALAISE 88 0.0002
678 AGEUSIA 5 0.0002
679 HYPOTONIA 2 0.0002
680 BRAIN INJURY 2 0.0002
681 LACRIMATION INCREASED 6 0.0002
682 FULL BLOOD COUNT DECREASED 4 0.0002
683 TASTE DISORDER 4 0.0002
684 NECK PAIN 11 0.0002
685 DRY THROAT 2 0.0002
686 FLUID RETENTION 10 0.0002
687 DRUG ADMINISTRATION ERROR 6 0.0002
688 ADVERSE EVENT 18 0.0002
689 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 35 0.0002
690 DRUG EFFECT INCOMPLETE 7 0.0002
691 PETECHIAE 2 0.0002
692 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 10 0.0002
693 ACCIDENTAL OVERDOSE 7 0.0002
694 SCRATCH 2 0.0002
695 SCIATICA 3 0.0002
696 NASAL CONGESTION 11 0.0002
697 GASTROOESOPHAGEAL REFLUX DISEASE 15 0.0002
698 PULMONARY THROMBOSIS 2 0.0002
699 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
700 CHOLELITHIASIS 6 0.0002
701 INTENTIONAL PRODUCT MISUSE 16 0.0002
702 IMPAIRED HEALING 6 0.0002
703 WHITE BLOOD CELL COUNT INCREASED 7 0.0002
704 GASTROINTESTINAL PAIN 2 0.0002
705 INJECTION SITE NODULE 2 0.0002
706 PRODUCT USE ISSUE 34 0.0002
707 DENTAL CARIES 2 0.0002
708 DISCOMFORT 11 0.0002
709 TOOTH DISORDER 4 0.0002
710 PAIN IN EXTREMITY 53 0.0002
711 MUSCLE SPASMS 33 0.0002
712 HAEMOPTYSIS 5 0.0002
713 SNEEZING 4 0.0002
714 INTESTINAL PERFORATION 2 0.0002
715 BLOOD CALCIUM DECREASED 2 0.0002
716 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 36 0.0002
717 CHROMATURIA 4 0.0002
718 IMPAIRED DRIVING ABILITY 2 0.0002
719 GASTRIC DISORDER 6 0.0002
720 DEVICE DEFECTIVE 3 0.0002
721 EYELID OEDEMA 2 0.0002
722 SPINAL PAIN 2 0.0002
723 DIABETES MELLITUS 13 0.0002
724 HEAD DISCOMFORT 3 0.0002
725 CHOLECYSTITIS 2 0.0002
726 PRODUCTIVE COUGH 8 0.0002
727 RASH PRURITIC 9 0.0002
728 CHEST DISCOMFORT 17 0.0002
729 HYPERTENSION 35 0.0002
730 ABDOMINAL PAIN UPPER 34 0.0002
731 BONE DISORDER 3 0.0002
732 NEURALGIA 4 0.0002
733 END STAGE RENAL DISEASE 3 0.0002
734 VERTIGO 10 0.0002
735 RECTAL HAEMORRHAGE 7 0.0002
736 ABDOMINAL DISTENSION 17 0.0002
737 GENERALISED OEDEMA 2 0.0002
738 HEART RATE INCREASED 16 0.0002
739 CYST 2 0.0002
740 BACK PAIN 37 0.0002
741 HYPOCALCAEMIA 3 0.0002
742 FOOT FRACTURE 3 0.0002
743 BLOOD URINE PRESENT 3 0.0002
744 VOMITING 74 0.0002
745 SLEEP APNOEA SYNDROME 3 0.0002
746 MOOD SWINGS 5 0.0002
747 INTRAOCULAR PRESSURE INCREASED 2 0.0002
748 DRUG INTOLERANCE 15 0.0002
749 HIATUS HERNIA 2 0.0002
750 HAEMATOMA 4 0.0002
751 INCORRECT DOSE ADMINISTERED 35 0.0002
752 VISION BLURRED 21 0.0002
753 SUICIDAL IDEATION 14 0.0002
754 APPLICATION SITE ERYTHEMA 4 0.0002
755 HAND DEFORMITY 2 0.0002
756 JOINT STIFFNESS 4 0.0002
757 INFECTION 22 0.0002
758 ANKYLOSING SPONDYLITIS 2 0.0002
759 PULMONARY CONGESTION 2 0.0002
760 STAPHYLOCOCCAL INFECTION 5 0.0002
761 ACTIVITIES OF DAILY LIVING IMPAIRED 3 0.0002
762 SINUS DISORDER 3 0.0002
763 HAEMATOCRIT DECREASED 3 0.0002
764 EXPIRED PRODUCT ADMINISTERED 5 0.0002
765 EYE HAEMORRHAGE 2 0.0001
766 CARDIAC DISORDER 14 0.0001
767 QUALITY OF LIFE DECREASED 2 0.0001
768 INTENTIONAL SELF-INJURY 3 0.0001
769 PRODUCT ADMINISTRATION ERROR 3 0.0001
770 EXTRA DOSE ADMINISTERED 6 0.0001
771 FLUSHING 15 0.0001
772 HYPOAESTHESIA 22 0.0001
773 TREATMENT NONCOMPLIANCE 8 0.0001
774 OSTEOPOROSIS 6 0.0001
775 DIVERTICULITIS 4 0.0001
776 PROCEDURAL PAIN 4 0.0001
777 ROAD TRAFFIC ACCIDENT 6 0.0001
778 DYSPNOEA 81 0.0001
779 RENAL FAILURE 19 0.0001
780 INCORRECT DRUG ADMINISTRATION DURATION 4 0.0001
781 SKIN REACTION 2 0.0001
782 ABDOMINAL PAIN 33 0.0001
783 MULTIPLE ORGAN DYSFUNCTION SYNDROME 4 0.0001
784 DRY EYE 7 0.0001
785 IRRITABLE BOWEL SYNDROME 3 0.0001
786 RED BLOOD CELL COUNT DECREASED 4 0.0001
787 PARALYSIS 2 0.0001
788 CELLULITIS 7 0.0001
789 PULMONARY ARTERIAL HYPERTENSION 2 0.0001
790 LIVER FUNCTION TEST ABNORMAL 4 0.0001
791 ARTHRALGIA 57 0.0001
792 NEUROPATHY PERIPHERAL 13 0.0001
793 PALPITATIONS 16 0.0001
794 APPLICATION SITE PAIN 3 0.0001
795 LABORATORY TEST ABNORMAL 4 0.0001
796 HOT FLUSH 10 0.0001
797 CONTRAINDICATED PRODUCT ADMINISTERED 4 0.0001
798 INSURANCE ISSUE 2 0.0001
799 FEELING HOT 8 0.0001
800 DEVICE ADHESION ISSUE 2 0.0001
801 PAIN 80 0.0001
802 OROPHARYNGEAL PAIN 12 0.0001
803 LYMPHOMA 2 0.0001
804 MUSCULOSKELETAL CHEST PAIN 2 0.0001
805 ANKLE FRACTURE 2 0.0001
806 LUNG INFECTION 2 0.0001
807 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 3 0.0001
808 INJURY 9 0.0001
809 CHILLS 15 0.0001
810 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 7 0.0001
811 CYANOSIS 2 0.0001
812 ARRHYTHMIA 6 0.0001
813 HAEMOGLOBIN DECREASED 13 0.0001
814 DEPRESSED LEVEL OF CONSCIOUSNESS 5 0.0001
815 PRODUCT PRESCRIBING ERROR 3 0.0001
816 RESPIRATORY TRACT CONGESTION 2 0.0001
817 ABSCESS 2 0.0001
818 NIGHT SWEATS 4 0.0001
819 FLATULENCE 7 0.0001
820 HERPES ZOSTER 7 0.0001
821 BRONCHITIS 9 0.0001
822 PHOTOSENSITIVITY REACTION 2 0.0001
823 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
824 MYOCARDIAL INFARCTION 21 0.0001
825 EPISTAXIS 9 0.0001
826 LIP SWELLING 4 0.0001
827 FUNGAL INFECTION 4 0.0001
828 EYE PRURITUS 4 0.0001
829 CHRONIC KIDNEY DISEASE 9 0.0001
830 CANDIDA INFECTION 2 0.0001
831 HEADACHE 74 0.0001
832 DIARRHOEA 76 0.0001
833 CIRCULATORY COLLAPSE 2 0.0001
834 MIGRAINE 11 0.0001
835 DEVICE USE ERROR 4 0.0001
836 PLEURAL EFFUSION 7 0.0001
837 NASOPHARYNGITIS 21 0.0001
838 LYMPHOCYTE COUNT DECREASED 2 0.0001
839 INJECTION SITE BRUISING 9 0.0001
840 CARDIAC FAILURE 9 0.0001
841 DRUG EFFECT DECREASED 6 0.0001
842 ELECTROCARDIOGRAM QT PROLONGED 4 0.0001
843 FREQUENT BOWEL MOVEMENTS 3 0.0001
844 OEDEMA 6 0.0001
845 SKIN LESION 3 0.0001
846 TINNITUS 5 0.0001
847 DRUG ABUSE 9 0.0001
848 DYSGEUSIA 8 0.0001
849 SWELLING FACE 7 0.0001
850 BLOOD CHOLESTEROL INCREASED 5 0.0001
851 BACTERIAL INFECTION 2 0.0001
852 HEPATIC CIRRHOSIS 2 0.0001
853 TARDIVE DYSKINESIA 3 0.0001
854 PHOTOPHOBIA 2 0.0001
855 DYSPNOEA EXERTIONAL 4 0.0001
856 RASH ERYTHEMATOUS 5 0.0001
857 PULMONARY FIBROSIS 2 0.0001
858 EYE IRRITATION 6 0.0001
859 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
860 BLOOD GLUCOSE DECREASED 5 0.0001
861 EAR PAIN 2 0.0001
862 WEIGHT INCREASED 23 0.0001
863 HEPATIC ENZYME INCREASED 7 0.0001
864 PLASMA CELL MYELOMA 4 0.0001
865 ORAL HERPES 2 0.0001
866 ASCITES 3 0.0001
867 DISABILITY 2 0.0001
868 THERAPEUTIC RESPONSE DECREASED 6 0.0001
869 INJURY ASSOCIATED WITH DEVICE 2 0.0001
870 SINUSITIS 10 0.0001
871 EMOTIONAL DISORDER 3 0.0001
872 PULMONARY HYPERTENSION 2 0.0001
873 GASTROINTESTINAL HAEMORRHAGE 8 0.0001
874 CARDIO-RESPIRATORY ARREST 4 0.0001
875 ECZEMA 5 0.0001
876 MUSCULOSKELETAL PAIN 5 0.0001
877 RENAL FAILURE ACUTE 4 0.0001
878 PSORIASIS 12 0.0001
879 PRODUCT DISPENSING ERROR 2 0.0001
880 EYE DISORDER 3 0.0001
881 DRUG WITHDRAWAL SYNDROME 8 0.0001
882 LIVER DISORDER 4 0.0001
883 STEVENS-JOHNSON SYNDROME 2 0.0001
884 MEDICATION ERROR 5 0.0001
885 ORAL PAIN 2 0.0001
886 PARAESTHESIA 14 0.0001
887 PANCREATITIS ACUTE 2 0.0001
888 PRODUCT USE IN UNAPPROVED INDICATION 22 0.0001
889 HYPONATRAEMIA 5 0.0001
890 HAEMATURIA 3 0.0001
891 PERICARDIAL EFFUSION 2 0.0001
892 RENAL DISORDER 4 0.0001
893 RASH MACULAR 3 0.0001
894 SWELLING 8 0.0001
895 HYPOXIA 3 0.0001
896 ACUTE KIDNEY INJURY 13 0.0001
897 CARDIAC ARREST 7 0.0001
898 WHEEZING 5 0.0001
899 PULMONARY EMBOLISM 8 0.0001
900 HEPATIC CANCER 2 0.0001
901 WHITE BLOOD CELL COUNT DECREASED 9 0.0001
902 C-REACTIVE PROTEIN INCREASED 3 0.0001
903 STOMATITIS 5 0.0001
904 HYPERGLYCAEMIA 3 0.0001
905 RESPIRATORY FAILURE 6 0.0001
906 FIBROMYALGIA 2 0.0001
907 LIVER INJURY 2 0.0001
908 OFF LABEL USE 71 0.0001
909 CHEST PAIN 15 0.0001
910 ABASIA 2 0.0001
911 PYREXIA 28 0.0001
912 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
913 COLITIS 3 0.0001
914 ANAEMIA 15 0.0001
915 ERYTHEMA 16 0.0001
916 SKIN ULCER 2 0.0001
917 BLOOD CREATININE INCREASED 5 0.0001
918 HAEMORRHAGE 8 0.0001
919 DEAFNESS 2 0.0001
920 PANCREATITIS 4 0.0001
921 BRADYCARDIA 4 0.0001
922 INJECTION SITE PRURITUS 5 0.0001
923 PROSTATE CANCER 6 0.0001
924 BLINDNESS 3 0.0001
925 PNEUMONITIS 2 0.0001
926 RASH 32 0.0001
927 DRUG DOSE OMISSION 12 0.0001
928 HAEMATOCHEZIA 4 0.0001
929 RESPIRATORY DISTRESS 2 0.0001
930 BURNING SENSATION 5 0.0001
931 EYE PAIN 4 0.0001
932 MYALGIA 12 0.0001
933 RHEUMATOID ARTHRITIS 8 0.0001
934 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
935 HYPERSENSITIVITY 13 0.0001
936 OVERDOSE 15 0.0001
937 PRODUCT SUBSTITUTION ISSUE 4 0.0001
938 INTENTIONAL PRODUCT USE ISSUE 6 0.0001
939 TACHYCARDIA 6 0.0001
940 DRY SKIN 9 0.0001
941 PLATELET COUNT DECREASED 7 0.0001
942 EPILEPSY 2 0.0001
943 HYPOKALAEMIA 3 0.0001
944 BLOOD GLUCOSE INCREASED 12 0.0001
945 OCULAR HYPERAEMIA 3 0.0001
946 RENAL CANCER 3 0.0001
947 HYPOTHYROIDISM 2 0.0001
948 THROMBOCYTOPENIA 7 0.0001
949 PRURITUS 24 0.0001
950 INTENTIONAL OVERDOSE 4 0.0001
951 ASTHMA 7 0.0001
952 HYPOGLYCAEMIA 3 0.0001
953 DEVICE EXPULSION 4 0.0001
954 LUNG DISORDER 3 0.0001
955 PRODUCT STORAGE ERROR 5 0.0001
956 HYPERKALAEMIA 2 0.0001
957 NO ADVERSE EVENT 10 0.0001
958 EYE SWELLING 2 0.0001
959 PANCYTOPENIA 3 0.0001
960 EMOTIONAL DISTRESS 6 0.0000
961 SUICIDE ATTEMPT 3 0.0000
962 INJECTION SITE ERYTHEMA 6 0.0000
963 COMPLETED SUICIDE 4 0.0000
964 COLITIS ULCERATIVE 2 0.0000
965 DEVICE MALFUNCTION 3 0.0000
966 ALOPECIA 8 0.0000
967 INFLAMMATION 2 0.0000
968 DERMATITIS ATOPIC 2 0.0000
969 ARTHROPATHY 2 0.0000
970 URTICARIA 6 0.0000
971 BLISTER 2 0.0000
972 TOXICITY TO VARIOUS AGENTS 6 0.0000
973 SKIN EXFOLIATION 3 0.0000
974 BONE PAIN 2 0.0000
975 BLADDER CANCER 2 0.0000
976 INJECTION SITE PAIN 10 0.0000
977 DEEP VEIN THROMBOSIS 2 0.0000
978 INFUSION RELATED REACTION 2 0.0000
979 PRODUCT QUALITY ISSUE 4 0.0000
980 NEUTROPENIA 4 0.0000
981 MALIGNANT NEOPLASM PROGRESSION 3 0.0000
982 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
983 INJECTION SITE REACTION 2 0.0000
984 INFLUENZA LIKE ILLNESS 2 0.0000
985 RENAL IMPAIRMENT 2 0.0000
986 BREAST CANCER 2 0.0000
987 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
988 DRUG DEPENDENCE 3 0.0000